SGX Regco grants SAM Holdings’ extension for FY 2024 results

The company filed the application on 16 August with SGX Regco.

The Singapore Institute of Advanced Medicine Holdings Ltd. (SAM Holdings) application for extension to submit its fiscal year 2024 (FY 2024) earnings results has been granted by the Singapore Exchange Regulation (SGX Regco), according to a bourse filing. 

This grants the company a two-month extension to release its FY 2024 results by 29 October and to convene its annual general meeting (AGM) by 31 December. 

They were also granted a two-month extension for the issuance of their AR2024 by 16 December, being at least 14 days before the date of its AGM. 

Additionally, the company is also expected to file an application to the Accounting and Corporate Regulatory Authority (ACRA) for an extension to hold its AGM 2024.